Crystal Crop Protection IPO — GMP Today, Price Band & Dates
Crystal Crop Protection IPO GMP Today
The current grey market premium (GMP) of the Crystal Crop Protection IPO is ₹13. GMP reflects unofficial demand for the shares before listing and moves with market sentiment and subscription numbers. This figure updates automatically every hour.
Key Details
| IPO Name | Crystal Crop Protection |
|---|---|
| Type | Mainboard |
| IPO Dates | 18-20 Nov 2026 |
| Price Band | ₹272 |
| GMP Today | ₹13 |
| Estimated Listing | ₹285 (4.78%) |
| Status | Upcoming |
Live data last refreshed: 16/11/2026, 17:26:32 IST
FAQ
What is the GMP of Crystal Crop Protection IPO today?
Crystal Crop Protection IPO GMP today is ₹13.
What are the Crystal Crop Protection IPO dates?
Crystal Crop Protection IPO dates: 18-20 Nov 2026.
Is Crystal Crop Protection a Mainboard or SME IPO?
Crystal Crop Protection is a Mainboard IPO.
Does GMP guarantee listing gains?
No. GMP is an unofficial, unregulated indicator and can change quickly. Always evaluate the company's fundamentals before investing.
About Crystal Crop Protection
Established in 1994, Crystal Crop Protection Limited is an Indian crop solutions company with agrochemicals and seeds at the core of its offerings. Its product portfolio comprises crop protection products such as herbicides, fungicides, insecticides, combinations, and natural crop solutions including bio-stimulants, bio-protectants, liquid fertilizers, and plant growth regulators. It also produces technical grade active ingredients and seeds covering field crops, vegetable crops, and flowers. The company operates six manufacturing units for crop protection and natural crop solutions (four formulation units and two technical manufacturing units across Jammu and Kashmir, Haryana, Gujarat, and Maharashtra), a technical pilot unit, an in-house R&D centre (KRDC) in Sonipat supported by nine field research stations, and three seed processing units in Telangana and Karnataka. Domestically, it is present across 23 states and four union territories with a distribution network of 14,717 independent distributors and 34 distribution centres as of June 30, 2026. It also exports to international markets.
Business Model
The company operates an integrated business model spanning R&D, manufacturing, regulatory registrations, brand-building, and distribution across three segments: Domestic Branded Business, Domestic Corporate Business, and International Business. It follows a two-brand strategy (Crystal and Saffire) with dedicated, non-overlapping distribution channels. Revenue is generated via B2C and B2B channels. B2C sales include branded crop protection products, natural crop solutions, and hybrid seeds sold to smallholder and progressive farmers. B2B sales comprise bulk and packed sales of technicals, formulations, and seeds to institutional customers, along with co-marketing arrangements and direct exports.
Financial Performance
| Metric | As at and for the three months ended June 30, 2026 | As at and for the Financial Year ended March 31, 2026 | As at and for the Financial Year ended March 31, 2025 | As at and for the Financial Year ended March 31, 2024 |
|---|---|---|---|---|
| Equity share capital | 1,274.64 | 1,274.64 | 1,274.64 | 1,274.64 |
| Net Worth | 21,741.80 | 20,397.61 | 16,001.03 | 14,883.85 |
| Revenue from operations | 11,971.49 | 31,519.68 | 26,905.10 | 22,299.27 |
| EBITDA | 2,417.76 | 4,562.29 | 3,152.76 | 2,090.61 |
| Profit after tax | 1,357.83 | 1,449.14 | 1,183.92 | 872.37 |
| Basic EPS (in ₹) | 10.66 | 11.43 | 9.37 | 7.02 |
| Diluted EPS (in ₹) | 9.72 | 11.06 | 9.37 | 7.02 |
| Return on Net Worth (in %) | 6.25 | 7.14 | 7.46 | 5.99 |
| Net asset value ("NAV") per equity share (in ₹) | 170.57 | 160.03 | 125.53 | 116.77 |
| Total borrowings | 9,520.23 | 8,200.39 | 9,470.23 | 5,772.93 |
| Net cash flow from operating activities | 434.68 | 2,564.15 | 3,830.29 | 3,377.87 |
| Net cash used in investing activities | (906.88) | (2,159.01) | (6,734.35) | (2,297.14) |
| Net cash from/ (used in) from financing activities | 1,133.84 | 101.59 | 2,788.21 | (951.00) |
All figures ₹ in million (except per share data and percentages) unless otherwise stated.
Figures as disclosed in the RHP filed with SEBI. Source: offer document.
Objects of the Issue
- Repayment/pre-payment, in full or part, of certain borrowings availed by the Company amounting to ₹2,479.42 million
- Investment in Material Subsidiary Saffire Crop Science Private Limited for repayment/pre-payment of its outstanding borrowings amounting to ₹220.58 million
- Funding inorganic growth through unidentified acquisitions and strategic initiatives, and general corporate purposes (amount not disclosed in excerpts)
Promoters
The promoters of the company are Nand Kishore Aggarwal (Chairman Emeritus), Ankur Aggarwal (Chairman and Managing Director), Komal Aggarwal, and Ankur Aggarwal KNK Family Trust. Together, the promoters held an 80.19% pre-offer equity shareholding on a fully diluted basis as of the date of the RHP.
Strengths
- Strong R&D capabilities backed by advanced technology infrastructure and collaborations.
- A deep connect with Indian farmers resulting in strong brand equity.
- Operational excellence with focus on a multi-pronged go-to-market strategy.
- Vertically integrated manufacturing operations backed by robust R&D and a strong supply chain.
- Strategic acquisitions and successful integration of growth opportunities.
Key Risks
- Ongoing criminal and regulatory proceedings against the Company, Promoters, and a Director involving ₹755.31 million (3.47% of Net Worth as of June 30, 2026).
- Outstanding legal proceedings involving the Company, Subsidiaries, Promoters, Directors, and KMPs/SMPs aggregating to ₹3,419.47 million (16.76% of Net Worth).
- Heavy reliance on domestic Indian demand, exposing operations to domestic economic cyclicality and industry downturns.
- Business is highly cyclical and vulnerable to adverse seasonal variations, climatic conditions, and pest attacks.
- Lack of long-term agreements with a majority of customers and distributors.
- Lengthy product development and registration cycles (5-7 years) in a highly regulated agrochemical and seeds environment.
Points to Weigh
- Revenue from operations grew from ₹22,299.27 million in Fiscal 2024 to ₹31,519.68 million in Fiscal 2026, alongside expanding EBITDA margins.
- Net debt-to-equity ratio stood at 0.41 as of June 30, 2026, with planned IPO debt repayments of ₹2,700 million across the parent and subsidiary.
- Investors must weigh exposure to pending regulatory and criminal proceedings that aggregate to 16.76% of net worth.
- The business model is subject to seasonal cyclicality, regulatory approval timelines of 5-7 years for innovations, and absence of long-term customer contracts.